AMMF Grants for Research
One of AMMF’s major objectives is to support specialised research teams in their work to find the causes, methods of earlier diagnosis, and effective treatments for cholangiocarcinoma (CCA).
AMMF has funded or is currently funding research at many of the leading research institutions across the UK and internationally:
- Imperial College London
- University College London
- The Institute of Hepatology London
- University of Birmingham
- University of Cambridge
- University of Edinburgh
- University of Nottingham
- University of East Anglia
- University of Manchester
- University of Liverpool
- University of Oxford
- University of Leeds
- Cardiff University
- Universities of Madrid, Navarra and Pamplona, Spain
- John Hopkins University, USA
- Sapienza University of Rome
- University of Copenhagen
- University of Glasgow
AMMF welcomes funding applications from research bodies for cholangiocarcinoma work. For more information, click here
University of Nottingham
Professor Sheela Jayaraman
Award £75,504.37
Awarded in 2025 to be given over three years, to support work investigating “New approaches for improved stent patency and tumour cell killing”.
Ref 2025/234
University of Birmingham
Mr Kayani Kayani
Award £99,317.67
Awarded in 2025 to support work investigating “Stable Functional Induced Tregs (SFiTregs): A novel means of immunosuppression for patients transplanted for cholangiocarcinoma in the era of transplant oncology”.
Ref 2025/233
University College London
Professor John Bridgewater
Award £20,503
Awarded in 2025 to support integration of SAFIR-ABC10 data into the ENS-CCA database.
Ref 2025/232
Wellcome Sanger Institute
Dr Ashray Gunjur
Award £16,780
Awarded in 2025 to support work investigating “The immune implications of intra-tumoural bacteria in cholangiocarcinoma: a translational research study using samples from the ‘CheckPAC’ phase II clinical trial”.
Ref 2025/231
University of Edinburgh
Ms Rachel Guest
Award £97,348.37
Awarded in 2025 to be given over two years, to support work investigating “The role of IDH mutation in liver cell plasticity and Intrahepatic Cholangiocarcinoma”.
Ref 2025/230
Henri Mondor University Hospital
Professor Julien Calderaro
Award €44,000
Awarded in 2025 to be given over two years, to support work investigating “AI-CCA: Artificial Intelligence as a Biomarker for Intrahepatic Cholangiocarcinoma”.
Ref 2025/229
Sapienza University of Rome
Dr Veronica Porreca
Award £40,000
Awarded in 2025 to be given over two years, to support work investigating “Targeting the adhesive functions in intrahepatic cholangiocarcinoma progression: focus on the cancer cell surface receptors engaged by the THBS1 and THBS2”.
Ref 2025/228
University of Leicester
Dr Ed Jarman
Award £50,000
Awarded in 2025 to be given over three years, to support work investigating “Does COX2 pattern the local immune environment to promote early neoplastic growth?”
Ref 2025/227
University College London Hospital
Dr Uma Mukherjee
Award £17,331.73
Awarded in 2024 to be given over 2 years, to support work investigating “Identifying and predicting resistance mutations in intrahepatic cholangiocarcinoma (iCCA)”
Ref 2024/225
Imperial College London
Professor Shahid Khan
Award £45,000
Awarded in 2024 to be given over 2 years, to support work investigating “Multiplexed detection of cell-free DNA, microRNA, and protein biomarkers to diagnose Cholangiocarcinoma and Hepatocellular Carcinoma using a novel nanopore-based sensing technology”
Ref 2024/226
University of Liverpool
Mr Marc Quinn
Award: £25,000
Awarded in 2023 to be given over 2 years, to support work investigating, “Unravelling intra-tumoral heterogeneity in cholangiocarcinoma through single cell RNA sequencing”.
Ref 2023/217
University of Oxford
Dr Shijie Cai
Award £56,002.57
Awarded for Year 1 and 2 postdoctoral salaries, to support work investigating “Normal cholangiocyte containment of cholangiocarcinoma through metabolic and transcriptomic regulation”.
Ref 2023/219
2024/222
University of Glasgow
Professor Chiara Braconi
Award £99,464.00
Awarded in 2023 to be given over 2 years, to support work investigating “Identifying therapeutic opportunities for Biliary Cancers by investigating the role of Monocytes in drug response”.
Ref 2023/218
University of Edinburgh
Dr Ed Jarman and Dr Paula Olaizola
Award £50,000.00
Awarded in 2023 to be given over 3 years, to support work investigating “Does retinol from hepatic stellate cells fuel tumour cells during cholangiocarcinoma initiation”.
Ref 2023/221
Sapienza University of Rome
Professor Carmine Mancone
Award: £35,000.00
Awarded in 2022 to be given over 2 years, to support work investigating “The role of THBS1, THBS2 and PEDF in the lymphatic dissemination of the intrahepatic cholangiocarcinoma: identification of downstream signalling pathway”.
Ref 2022/211
University of Copenhagen
Professor Jesper Andersen
Award: £45,339.00
Awarded in 2022 to support work investigating “Tumour phenotypes and sensitivities triggered by IL-6 activation in intrahepatic cholangiocarcinoma”.
Ref 2022/212
University of Manchester
Dr Alicia-Marie Conway
Award: £30,850.00
Awarded in 2022 to support work investigating “Intrahepatic cholangiocarcinoma hidden amongst the Unknown: biomarker discovery and novel diagnostic approach from circulation: Free DNA (cfDNA) in cancers of unknown primary”.
Ref 2022/216
University of Nottingham
Professor Kevin Gaston
Award: £24,250.00
Awarded in 2022 to support work investigating “Ultra high-resolution mapping of spatial patterns of gene and protein expression in cholangiocarcinoma and the cholangiocarcinoma tumour microenvironment”.
Ref 2022/214
University of Nottingham
Professor Sheela Jayaraman
Award: £22,000.00
Awarded in 2022 to support work investigating “Combination therapies for Cholangiocarcinoma”.
Ref 2022/215
University of Nottingham
Professor Sheela Jayaraman
Award: £19,260
Awarded in 2019 to be given over 3 years, to support work investigating, “New strategies for the inhibition of Cholangiocarcinoma tumour growth”.
Ref 2019/204
Recently Completed Grants
For information on some of the recently completed AMMF awards for research, click here
AMMF Research Grants – Applications
One of AMMF’s major objectives is to support specialised research teams in their work to find the causes, methods of earlier diagnosis, and effective treatments for cholangiocarcinoma (CC). AMMF welcomes funding applications from research bodies for cholangiocarcinoma work. For more details, and how to apply for funding, please click here
